Fludeoxyglucose (18F)

DB09502ApprovedInvestigationalSmall moleculeRadioactive Diagnostic Agent

Fludeoxyglucose (18F) is a radiopharmaceutical agent used for positron emission tomography (PET) imaging in oncology, cardiology, and neurology. It is administered by intravenous injection.

Chemical structure of Fludeoxyglucose (18F)
Mechanism
Curator reviewed
Primary indication
The uptake of 18F-FDG by tissues is a marker for the tissue uptake of glucose, which in turn is closely correlated with certain types of tissue metabolism.Curator reviewed · 4 structured indications
Formula / weight
C6H11FO5 · 181.15 g/mol (avg)
First approval
United States, 2005
Also known as
(18F)-FDG · 18-F FDG · 18F-FDG · 18F-Fluorodeoxyglucose · Fludeoxyglucose F 18

Resolves to

Structure
InChIKeyAOYNUTHNTBLRMT-MXWOLSILSA-NSMILES[H]C(=O)[C@H]([18F])[C@@H](O)[C@H](O)[C@H](O)CO

What you can answer from here — as of July 11, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
12TransportersSubstrate / inhibitor direction, not just membership
Listed above
733Drug interactionsStructured to mechanism, not free text
Sign in
138Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
79Marketed productsAcross 6 countries and 61 labellers
Sign in
1ATC codeIncluding every combination product, plus 13 drug categories
Sign in
37+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Fludeoxyglucose (18F), and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account